Page last updated: 2024-11-06

2-cresolphthalexon

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-cresolphthalexon: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID75485
SCHEMBL ID8654467
MeSH IDM0068918

Synonyms (37)

Synonym
2411-89-4
cresolphthalexon
nsc298195
glycine,n'-[(3-oxo-1(3h)-isobenzofuranylidene)bis[(6-hydroxy-5-methyl-3,1-phenylene)methylene]]bis[n-(carboxymethyl)-
3,n-di(carboxymethyl)aminomethyl]-o-cresolphthalein
phenolphthalein,3''-bis[[bis(carboxymethyl)amino]methyl]-5',5''-dimethyl-
o-cresolphthalexon
nsc-298195
2-cresolphthalexon
2-[[5-[1-[3-[[bis(carboxymethyl)amino]methyl]-4-hydroxy-5-methylphenyl]-3-oxo-2-benzofuran-1-yl]-2-hydroxy-3-methylphenyl]methyl-(carboxymethyl)amino]acetic acid
2-[[5-[1-[3-[[bis(carboxymethyl)amino]methyl]-4-hydroxy-5-methyl-phenyl]-3-oxo-isobenzofuran-1-yl]-2-hydroxy-3-methyl-phenyl]methyl-(carboxymethyl)amino]acetic acid
A817106
1,3-dihydro-3-oxoisobenzofuran-1-ylidenebis(6-hydroxy-5-methyl-m-phenylenemethylenenitrilo)tetra-acetic acid
a4p6737i7f ,
unii-a4p6737i7f
nsc 298195
n,n'-((3-oxo-1(3h)-isobenzofuranylidene)bis((6-hydroxy-5-methyl-3,1-phenylene)methylene))bis(n-(carboxymethyl)glycine
einecs 219-318-8
3,3'-bis(n,n-di(carboxymethyl)aminomethyl)-o-cresolphthalein
glycine, n,n'-((3-oxo-1(3h)-isobenzofuranylidene)bis((6-hydroxy-5-methyl-3,1-phenylene)methylene))bis(n-(carboxymethyl)-
FT-0634254
AKOS015903248
3,3'-bis(n,n-bis(carboxymethyl)aminomethyl)-o-cresolphthalein
n,n'-((3-oxo-1(3h)-isobenzofuranylidene)bis((6-hydroxy-5-methyl-3,1-phenylene)methylene))bis(n-(carboxymethyl)glycine)
o-cresolphthalexone
glycine, n,n'-[(3-oxo-1(3h)-isobenzofuranylidene)bis[(6-hydroxy-5-methyl-3,1-phenylene)methylene]]bis[n-(carboxymethyl)-
DTXSID5062392
SCHEMBL8654467
J-610053
mfcd00005911
glycine,n,n'-[(3-oxo-1(3h)-isobenzofuranylidene)bis[(6-hydroxy-5-methyl-3,1-phenylene)methylene]]bis[n-(carboxymethyl)-
Q907634
2,2',2'',2'''-(5,5'-(3-oxo-1,3-dihydroisobenzofuran-1,1-diyl)bis(2-hydroxy-3-methyl-5,1-phenylene))bis(methylene)bis(azanetriyl)tetraacetic acid
BS-43771
CS-0169030
phthalate complexing agent [chelation indicator]
HY-W110896

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Serum calcium was dosed in duplicate by conventional colorimetric techniques involving o-cresol-phthalein complexone (OCP) or methylthymol blue (MTB) as reagents."( Interference of magnetic resonance imaging contrast agents with the serum calcium measurement technique using colorimetric reagents.
Berthommier, C; Corot, C; Devoldere, L; Diai, A; Idee, JM; Lin, J; Port, M; Raynal, I; Robert, M, 1999
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (42.86)18.7374
1990's4 (19.05)18.2507
2000's4 (19.05)29.6817
2010's3 (14.29)24.3611
2020's1 (4.76)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.33

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.33 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index4.46 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.33)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.55%)6.00%
Case Studies1 (4.55%)4.05%
Observational0 (0.00%)0.25%
Other20 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]